Advisory Resource Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
1,685
+1,070
+174% +$1.09M 0.3% 82
2026
Q1
$565K Buy
615
+3
+0.5% +$3.04K 0.1% 130
2025
Q4
$658K Sell
612
-1
-0.2% -$956 0.12% 121
2025
Q3
$468K Sell
613
-1,401
-70% -$1.04M 0.08% 135
2025
Q2
$1.57M Buy
2,014
+82
+4% +$63.7K 0.3% 70
2025
Q1
$1.6M Buy
1,932
+41
+2% +$34.1K 0.33% 71
2024
Q4
$1.46M Buy
1,891
+207
+12% +$171K 0.31% 66
2024
Q3
$1.49M Sell
1,684
-48
-3% -$43.2K 0.32% 66
2024
Q2
$1.57M Buy
1,732
+52
+3% +$41.6K 0.35% 62
2024
Q1
$1.31M Sell
1,680
-50
-3% -$35.6K 0.3% 64
2023
Q4
$1.01M Buy
1,730
+1,118
+183% +$653K 0.25% 69
2023
Q3
$329K Hold
612
0.09% 123
2023
Q2
$287K Sell
612
-3
-0.5% -$1.26K 0.08% 131
2023
Q1
$211K Buy
615
+4
+0.7% +$1.35K 0.06% 144
2022
Q4
$224K Buy
+611
New +$217K 0.07% 137
2021
Q1
Sell
-2,357
Closed -$398K 120
2020
Q4
$398K Hold
2,357
0.2% 62
2020
Q3
$349K Buy
+2,357
New +$365K 0.2% 62
2019
Q3
Sell
-2,722
Closed -$302K 79
2019
Q2
$302K Hold
2,722
0.17% 56
2019
Q1
$316K Buy
2,722
+898
+49% +$109K 0.18% 57
2018
Q4
$211K Buy
+1,824
New +$204K 0.13% 59

Other funds holding LLY

Advisory Resource Group's LLY Position: Q2 2026 in Review

Advisory Resource Group increased its Eli Lilly (LLY) stake by 174% in Q2 2026, buying an estimated $1.09M and bringing the position to 1,685 shares worth $2.02M. The position accounts for 0.3% of the portfolio, ranked #82.

Advisory Resource Group first reported a position in LLY in Q4 2018 and has held it in 20 quarters since. 761 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Advisory Resource Group held 1,685 shares of Eli Lilly worth $2.02M as of Q2 2026.
  • Advisory Resource Group bought 1,070 Eli Lilly shares in Q2 2026, an estimated $1.09M.
  • Eli Lilly made up 0.3% of Advisory Resource Group's portfolio in Q2 2026, its #82 holding.
  • Advisory Resource Group first reported a position in Eli Lilly in Q4 2018 and has held it in 20 quarters since.
  • 761 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Advisory Resource Group's 13F filing for Q2 2026, filed 14 Jul 2026.